Synapticure
Summer 2020 · Active
We deliver personalized medicine for neurodegenerative patients
Location: Chicago, IL, US
Founded: 2019
Team size: 35
About
Founders
Peter WallachFounding CEO, Founder
Founder / Founding CEO, SynaptiCure Inc. Eternal optimist. Recovering Bain consultant and avid baseball fan.
Brian WallachFounder
Brian Wallach is an attorney and ALS patient. In the aftermath of his diagnosis in November 2017, he and his wife founded I AM ALS, a patient-led, patient-centric movement to lead the fight for a cure to the disease. Wallach is also an associate at the law firm Skadden, Arps, Slate, Meagher & Flom LLP. From 2014 to 2018, he served as an assistant United States attorney in the Northern District of Illinois. From 2011 to 2013, he was senior vetting counsel in the Obama White House.
Martina de MajoFounder
Martina is the director of research and development at Synapticure and she focuses on creating iPSC derived in vitro models to study neurodegenerative disorders. Martina received an undergraduate degree in biotechnology and a Master's degree in pharmaceutical biotechnology from the University of Rome "La Sapienza" (Italy), she then earned a PhD in clinical neuroscience from King's College London (UK) and deepened her knowledge of iPSC derived modelling in her postdoc at UCSF (US)